«Sarcomastigophora

Below is an extended Sarcomastigophora patents listing. Click here to return to the Sarcomastigophora main in depth entry.

Patents :
US Patent No.	Title
4968795	Substituted 1,2,4-triazinediones, processes for their preparation and their use
5585403	Sterilizing agent for preventing coccidiosis in animals
5656745	Nucleotide analogs
5659023	Nucleotide analogues
5683888	Modified bioluminescent proteins and their use
5693771	Methods for making nucleoside analogs
5717095	Nucleotide analogs
5750729	Compounds and methods for making and using same
5753235	Recombinant canine herpesviruses
5767100	Compounds and methods for making and using same
5798340	Nucleotide analogs
5538978	9-purinyl phosphonic acid derivatives
5527803	9-purinyl phosphonic acid derivatives
5494912	9-purinyl phosphonic acid derivitives for treating gout
4988680	Phosphonoalkylpurine derivatives
5023260	Substituted uracils, processes for their preparation and their use against parasitic protozoa
5057314	Low molecular weight antiviral factors
5114938	Parasiticidal substituted hexahydro-1,2,4-triazinediones and use thereas
5141938	Parasiticidal substituted 1,2,4-triazinediones
5196450	Method of inhibiting protozoal growth
5196562	Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
5214043	Parasiticidal substituted hexahydro-1,2,4-triazinediones
5256631	Substituted 1,2,4-triazinediones, and their use
5482956	Method of treating parastic protozoa with substituted benzimidazoles
5804197	Recombinant canine herpesviruses
5886179	Nucleotide analogs
6573060	Methods and compositions for targeting DNA metabolic processes using aminoglycoside derivatives
6610478	Phenotypic conversion of cells mediated by external guide sequences
6620833	Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas
6949567	Compounds for the treatment of protozoal diseases
7041813	Canine herpes virus alpha transinducing factor nucleic acid molecules
7071355	Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
7087728	Carbohydrate crosslinked glycoprotein crystals
7176241	Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
7247736	Method of identifying inhibitors of DHODH
7276606	Phenantridine analogues and uses thereof
6569881	Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa
6558954	Phenotypic conversion of cells mediated by external guide sequences
6552192	Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
5977061	N.sup.6 - substituted nucleotide analagues and their use
6020144	Sustained delivery device comprising a Leishmania protozoa and methods of making and using the same
6034116	Mixtures of substituted benzimidazoles with polyether antibiotics or synthetic coccidiostats as agents for use against parasitic protozoa
6159478	Recombinant canine herpesviruses
6225460	Nucleotide analogs
6359118	Carbohydrate crosslinked glycoprotein crystals
6410250	Sustained delivery device and methods of making and using the same
6440665	Modified bioluminescent proteins and their use
6500933	Methods of preparing carbohydrate crosslinked glycoprotein crystals
6537791	Mammalian DNA-dependent ATPase a polypeptides and fusions thereof
7423057	Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.